Anatomical loci of HIV-associated immune activation and association with viraemia

被引:57
作者
Iyengar, S
Chin, B
Margolick, JB
Sabundayo, BP
Schwartz, DH
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Radiol, Div Nucl Med, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S0140-6736(03)14363-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Lymphocyte activation, associated with vaccination or infection, can be measured by positron emission tomography (PET). We investigated the ability of PET to detect and measure magnitude of lymph-node activation among asymptomatic HIV-1-infected individuals. Methods Initially we assessed PET response in eight HIV-1-uninfected individuals who had received licensed killed influenza vaccine. In an urban teaching hospital, we recruited 12 patients recently infected with HIV-1 (<18 months since seroconversion) and 11 chronic long-term HIV-1 patients who had stable viraemia by RT-PCR (non-progressors). After injection with fluorine-18-labelled fluorodeoxyglucose, patients underwent PET. We correlated summed PET signal from nodes with viral load by linear regression on log-transformed values. Findings Node activation was more localised after vaccination than after HIV-1 infection. In early and chronic HIV-1 disease, node activation was greater in cervical and axillary than in inguinal and iliac chains (p<0.0001), and summed PET signal correlated with viraemia across a 4 log range (r(2)=0.98, p<0.0001). Non-progressors had small numbers of persistently active nodes, most of which were surgically accessible. Interpretation The anatomical restriction we noted may reflect microenvironmental niche selection, and tight correlation of PET signal with viraemia suggests target-cell activation determines steady-state viral replication.
引用
收藏
页码:945 / 950
页数:6
相关论文
共 32 条
[1]  
Adams S, 1998, J NUCL MED, V39, P1155
[2]  
Akhurst, 2000, Clin Positron Imaging, V3, P57, DOI 10.1016/S1095-0397(00)00041-8
[3]   Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover [J].
Anthony, KB ;
Yoder, C ;
Metcalf, JA ;
DerSimonian, R ;
Orenstein, JM ;
Stevens, RA ;
Falloon, J ;
Polis, MA ;
Lane, HC ;
Sereti, I .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) :125-133
[4]   METABOLIC CHANGES IN ACTIVATED T-CELLS - AN NMR-STUDY OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
BENTAL, M ;
DEUTSCH, C .
MAGNETIC RESONANCE IN MEDICINE, 1993, 29 (03) :317-326
[5]   Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection [J].
Blattman, JN ;
Sourdive, DJD ;
Murali-Krishna, K ;
Ahmed, R ;
Altman, JD .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6081-6090
[6]   Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species [J].
Brand, KA ;
Hermfisse, U .
FASEB JOURNAL, 1997, 11 (05) :388-395
[7]   RETRACTED: HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death (Retracted article. See vol. 120, pg. 3401, 2010) [J].
Brodie, SJ ;
Patterson, BK ;
Lewinsohn, DA ;
Diem, K ;
Spach, D ;
Greenberg, PD ;
Riddell, SR ;
Corey, L .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (10) :1407-1417
[8]   CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection [J].
Chen, G ;
Shankar, P ;
Lange, C ;
Valdez, H ;
Skolnik, PR ;
Wu, LJ ;
Manjunath, N ;
Lieberman, J .
BLOOD, 2001, 98 (01) :156-164
[9]  
Chen JJY, 2002, J LEUKOCYTE BIOL, V72, P271
[10]   Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production [J].
d'Ettorre, G ;
Forcina, G ;
Andreotti, M ;
Sarmati, L ;
Palmisano, L ;
Galluzzo, CM ;
Nicastri, E ;
Mastroianni, CM ;
Vullo, V ;
Vella, S ;
Andreoni, M .
AIDS, 2002, 16 (14) :1877-1885